Attached files
| file | filename |
|---|---|
| EX-4.5 - EXHIBIT 4.5 - ARGOS THERAPEUTICS INC | exh_45.htm |
| EX-31.2 - EXHIBIT 31.2 - ARGOS THERAPEUTICS INC | exh_312.htm |
| EX-31.1 - EXHIBIT 31.1 - ARGOS THERAPEUTICS INC | exh_311.htm |
| EX-23.1 - EXHIBIT 23.1 - ARGOS THERAPEUTICS INC | exh_231.htm |
| EX-10.44 - EXHIBIT 10.44 - ARGOS THERAPEUTICS INC | exh_1044.htm |
| EX-10.40 - EXHIBIT 10.40 - ARGOS THERAPEUTICS INC | exh_1040.htm |
| EX-10.28 - EXHIBIT 10.28 - ARGOS THERAPEUTICS INC | exh_1028.htm |
| EX-4.3 - EXHIBIT 4.3 - ARGOS THERAPEUTICS INC | exh_43.htm |
| 10-K - FORM 10-K - ARGOS THERAPEUTICS INC | f10k_031617p.htm |
Exhibit 32.1
CERTIFICATIONS PURSUANT TO 18 U.S.C. 1350
The undersigned, the Chief Executive Officer and the Vice President of Finance (principal financial officer) of Argos Therapeutics, Inc. (the “Company”), each hereby certifies that, to his/her knowledge on the date hereof:
(a) the Annual Report on Form 10-K of the Company for the period ended December 31, 2016 filed on the date hereof with the Securities and Exchange Commission (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(b) information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| By: | /S/ JEFFREY D. ABBEY | |
| Jeffrey D. Abbey | ||
| Chief Executive Officer | ||
| March 16, 2017 |
| By: | /S/ RICHARD D. KATZ, M.D. | |
|
Richard D. Katz, M.D. Vice President and Chief Financial Officer | ||
| March 16, 2017 |